All articles
Is Mounjaro Safe? Clinical Insights and Considerations for Patients
Is Mounjaro Safe? Clinical Insights and Considerations for Patients
Dr. Zoë Lees (PhD)
Dr. Sophie Dix (BSc, PhD)
30 December 2025 | Updated: 4 August 2026
4 August 2026
If you’re considering starting weight loss medication, it’s normal to have questions about safety and side effects. This guide provides clinical insights and key considerations to help you decide whether Mounjaro is the right option for you.
Article Summary:
- Mounjaro (tirzepatide) is a once-weekly injection used for weight loss and type 2 diabetes, helping control blood sugar and reduce appetite. It mimics the GLP-1 and GIP hormones to promote weight loss.
- Common side effects include nausea, vomiting and constipation. However, these can be managed with lifestyle interventions and usually subside on their own.
- More serious side effects, including allergic reactions, gallbladder issues and kidney problems, require immediate medical attention.
- Always use Mounjaro under the supervision of a healthcare professional.
How Mounjaro Works
Mounjaro is a medicine that reduces appetite and controls blood sugar. It mimics two natural hormones in your body called GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). These hormones help your body release the right amount of insulin and make you feel full after eating.
Here’s how Mounjaro works in your body:
- Mounjaro works in the brain to help you feel less hungry and fuller after eating. It helps quiet "food noise," which means those constant thoughts about food, like what to eat, when to eat, or how much to eat.
- Mounjaro slows down how quickly food leaves your stomach, helping you stay fuller for longer.
- After you eat, Mounjaro helps your body make more insulin, which keeps your blood sugar levels steady. It also helps your body use insulin better, so sugar can move from your blood into your cells more easily. This helps keep your blood sugar in a healthy range and can reduce food cravings.
In clinical trials, patients taking tirzepatide (the active ingredient in Mounjaro) experienced average weight loss of around 21% after 72 weeks of treatment. Compared with other injectable weight loss medications such as Ozempic or Wegovy, Mounjaro has shown greater average weight reduction. However, you should always work with a healthcare provider to find the best treatment for your needs. [1]
Common Side Effects
The most common side effects of Mounjaro are gastrointestinal (meaning they are related to the digestive system), including nausea, diarrhoea, constipation and vomiting. These symptoms are usually mild to moderate and tend to get better as the body adjusts to the medication. Eating smaller meals, staying hydrated, and avoiding spicy or fatty foods can help manage these effects. [2]
Serious Risks and Complications
While rare, serious side effects can occur with Mounjaro use. These include:
- Pancreatitis
- Gallbladder issues
- Kidney problems
- Severe allergic reaction (anaphylaxis)
Look out for symptoms such as severe stomach pain that spreads to your back, persistent vomiting, sudden sharp pain in the upper right belly that radiates to your shoulder or worsens when you breathe deeply, trouble breathing, swelling of your lips, tongue, or throat or a rapid heartbeat. These could signal serious problems.
You should seek immediate medical attention by calling 999 or going to A&E if you experience severe abdominal pain or persistent and severe vomiting. [2]
Use in Pregnant or Breastfeeding Individuals
Mounjaro should not be used during pregnancy or breastfeeding. You should stop taking Mounjaro at least 1 month before trying to get pregnant because of how long it stays in your system. [2]
Interaction with Other Medications
Mounjaro may affect how your body absorbs some medications, including the contraceptive pill. To help prevent an unplanned pregnancy while taking Mounjaro (tirzepatide), use a non-oral contraceptive method, such as an IUD, or add a barrier method like condoms. [2]
Importance of Medical Supervision
Mounjaro should only be used under the supervision of a healthcare provider, as it requires a prescription. A clinician will check is the medication is suitable for you based on your health history, current medication and treatment goals. You’ll also have regular check-ins to help make sure your dose is working well for you, and that side effects are managed safely.
Ready to Start Your Weight Loss Journey?
At MedExpress, we’re here to support you through your whole weight loss journey. If you’re thinking about getting started, complete a consultation on our website.
References
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine [Internet]. 2022 Jun 4;387(3):205–16. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
- Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc) [Internet]. www.medicines.org.uk. Available from: https://www.medicines.org.uk/emc/product/15481/smpc
Next scheduled review date: 4 August 2029
Semaglutide Tablets For Weight Loss: How They Work, Benefits And Side Effects
What Is Fibremaxxing? The Fibre Trend Explained By Our Experts
Foundayo Dosing: Which Strength Is Right For You?
Foundayo vs Wegovy Pill: How the Two Oral GLP-1 Weight Loss Tablets Compare
Authors
Written by: Dr. Zoë Lees (PhD)
Dr. Zoë Lees is a medical writer at MedExpress specialising in obesity and health communication. She completed her PhD at the University of Glasgow, where she investigated adipose tissue (fat tissue) function in pregnancies complicated by pre-eclampsia and gestational diabetes. Her work focuses on translating complex clinical evidence into clear, engaging and evidence-based health information for patients and the public. At MedExpress, Zoë contributes to clinical content, educational resources and media communications across areas including weight management, GLP-1 therapies and metabolic disease. Zoë is particularly interested in improving public understanding of obesity as a chronic condition and ensuring patients have access to accurate, accessible health information grounded in current scientific evidence.
Medically reviewed by: Dr. Sophie Dix (BSc, PhD)
Dr. Sophie Dix is Head of Medical Affairs at MedExpress. A behavioural neuroscientist by training, Sophie has spent 30 years working at the intersection of medical research, pharmacology, technology and patient communication across the pharmaceutical industry, health technology and charity sectors. At MedExpress, Sophie's role is to ensure that everything the organisation does is grounded in the most current science. That means translating complex clinical evidence into accessible health information across the website, clinical pathways and media communications. It also means working with external press and broadcast media as a named expert commentator, making the science behind weight management and GLP-1 treatments understandable to a general audience. A core part of Sophie's work is building MedExpress's Real-World Evidence (RWE) programme: learning systematically from patient outcomes to understand what works in practice, not just in clinical trials. This patient-level insight feeds directly into improving patient experience and health outcomes. Sophie believes that patients make better decisions when they have access to accurate, evidence-based information. As an advocate for meaningful change in how obesity is understood, Sophie works to reduce stigma and raise awareness of the condition as an illness. This includes reframing the conversation around GLP-1s from aesthetics to public health, while highlighting the health benefits of weight loss and weight management.
Note from the experts
Remember: This blog shouldn’t be regarded as medical advice, diagnosis, or treatment. We make sure everything we publish is fact checked by clinical experts and regularly reviewed, but it may not always reflect the most recent health guidelines. Always speak to your doctor about any health concerns you have.